Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TFPI | P10646 | 1/20 | 0.62 |
| ▸ | IL23R | Q5VWK5 | 13/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29426546 | 1.00 | TFPI (0.62) | TFPIIL23R | |
| SCHEMBL30577892 | 0.98 | IL23R (0.62) | TFPIIL23R | |
| SCHEMBL29372983 | 0.97 | TFPI (0.64) | TFPIIL23R | |
| SCHEMBL22807671 | 0.97 | TFPI (0.64) | TFPIIL23R | |
| SCHEMBL30413638 | 0.96 | IL23R (0.61) | TFPIIL23R | |
| SCHEMBL31504570 | 0.94 | TFPI (0.67) | TFPIIL23R | |
| SCHEMBL30973957 | 0.94 | TFPI (0.64) | TFPIIL23R | |
| SCHEMBL31031575 | 0.94 | TFPI (0.64) | TFPIIL23R | |
| SCHEMBL30414074 | 0.94 | TFPI (0.60) | TFPIIL23R | |
| SCHEMBL30577891 | 0.94 | IL23R (0.63) | TFPIIL23R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 261 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4746916-A2 | CLEAVABLE POLYMER-DRUG CONJUGATES FOR ALZHEIMER'S DISEASE | University of Utah Research Foundation (US) | 2026-05-27 | — | — | EP | claimed |
| CN-121015904-B | Method for regulating and controlling beta-amyloid aggregation based on circularly polarized light and application thereof | CHANGCHUN INSTITUTE OF APPLIED CHEMISTRY CHINESE ACADEMY OF SCIENCES (CN) | 2026-05-26 | — | — | CN | claimed |
| EP-4554563-B1 | REVERSED MICELLES FOR DELIVERY OF HYDROPHILIC DRUGS | CONSIGLIO NAZ DELLE RICERCHE CNR (IT) | 2026-02-25 | — | — | EP | claimed |
| US-20260007770-A1 | REVERSED MICELLES FOR DELIVERY OF HYDROPHILIC DRUGS | CONSIGLIO NAZIONALE RICERCHE (IT) | 2026-01-08 | — | — | US | claimed |
| US-20250381277-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF NEUROLOGICAL DISORDERS | DANA FARBER CANCER INST INC (US) | 2025-12-18 | — | — | US | claimed |
| US-20250332298-A1 | PEPTIDE-COUPLED ALGINATE GELS COMPRISING RADIONUCLIDES | BLUE WAVE THERAPEUTICS GMBH (CH) | 2025-10-30 | — | — | US | claimed |
| WO-2025201467-A1 | POLYPEPTIDE OLIGONUCLEOTIDE CONJUGATE FOR INHIBITING EXPRESSION OF TARGET GENE IN CENTRAL NERVOUS SYSTEM AND USE THEREOF | 广州必贝特医药股份有限公司 | 2025-10-02 | — | — | WO | claimed |
| EP-4611783-A1 | GENE THERAPY CONSTRUCTS FOR METABOLIC DISORDERS | Erasmus University Rotterdam Medical Center (NL) | 2025-09-10 | — | — | EP | claimed |
| CN-120077136-A | SiRNA and drug for inhibiting Amyloid Precursor Protein (APP) gene expression and application thereof | 广州必贝特医药股份有限公司 | 2025-05-30 | — | — | CN | claimed |
| WO-2025104335-A1 | MITOCHONDRIAL INTERVENTION IN NEUROLOGICAL DISORDERS | RASSAF TIENUSH (DE) | 2025-05-22 | — | — | WO | claimed |
| CN-117177747-A | Targeted bifunctional degradants and methods of use thereof | 耶鲁大学 | 2023-12-05 | — | — | CN | claimed |
| WO-2023225204-A1 | METHOD FOR TREATING CANCER | SUNTEC MEDICAL, INC. (US) | 2023-11-23 | — | — | WO | claimed |
| CN-116999580-A | Preparation method and application of polypeptide boron carrier radiopharmaceutical | 北京大学深圳研究生院 | 2023-11-07 | — | — | CN | claimed |
| WO-2022178428-A9 | TARGETED BIFUNCTIONAL DEGRADERS AND METHODS USING SAME | YALE UNIVERSITY (US) | 2023-08-17 | — | — | WO | claimed |
| WO-2023150552-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF NEUROLOGICAL DISORDERS | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2023-08-10 | — | — | WO | claimed |
| US-20230233689-A1 | Bifunctional Small Molecules to Target the Selective Degradation of Circulating Proteins | UNIV YALE (US) | 2023-07-27 | — | — | US | claimed |
| WO-2023066994-A1 | PEPTIDE-COUPLED ALGINATE GELS COMPRISING RADIONUCLIDES | BLUE WAVE THERAPEUTICS GMBH (CH) | 2023-04-27 | — | — | WO | claimed |
| US-20230083388-A1 | Bifunctional Small Molecules to Target the Selective Degradation of Circulating Proteins | UNIV YALE (US) | 2023-03-16 | — | — | US | claimed |
| US-11504394-B2 | Targeted ionophore-based metal delivery | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2022-11-22 | — | — | US | claimed |
| WO-2022178425-A1 | TARGETED BIFUNCTIONAL DEGRADERS | YALE UNIVERSITY (US) | 2022-08-25 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230233689-A1 | Bifunctional Small Molecules to Target the Selective Degradation of Circulating Proteins | ASGR1, LDLR, FCGR2A | TFPI 1162/4885IL23R 1101/4885 |
| US-20260007770-A1 | REVERSED MICELLES FOR DELIVERY OF HYDROPHILIC DRUGS | ABCB11, ABCC1, ABCE1 | TFPI 1132/4885IL23R 4054/4885 |
| US-11504394-B2 | Targeted ionophore-based metal delivery | SLC8B1, SLC47A2, ATP2A2 | TFPI 3878/4885IL23R 4738/4885 |
| US-20230083388-A1 | Bifunctional Small Molecules to Target the Selective Degradation of Circulating Proteins | ASGR1, LDLR, FCGR2A | TFPI 1162/4885IL23R 1101/4885 |
| US-20250332298-A1 | PEPTIDE-COUPLED ALGINATE GELS COMPRISING RADIONUCLIDES | ALG1, ALG3, GRPR | TFPI 4688/4885IL23R 891/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.